Medicine Overview

Indication

Know Medicine, Follow Guideline

Adult Dose

Clinical InformationAdministration Information
Indication: Pulmonary Arterial Hypertension
Condition: Normal liver function
Dose: Tablet – 200 mcg
Frequency: twice daily
Note: Starting dose. Increase dose by increments of 200 mcg twice daily, usually at weekly intervals, to the highest tolerated dose; not to exceed 1600 mcg twice daily. Route: by mouth.
Indication: Pulmonary Arterial Hypertension
Condition: Mild hepatic impairment (Child-Pugh A)
Dose: Tablet
Note: No dosage adjustment required.

Child Dose

Clinical InformationAdministration Information
Age: Pediatric
Dose: No approved pediatric dosage available
Note: No approved pediatric dosage available

Renal Dose

Clinical InformationAdministration Information
Condition: Renal impairment
Dose: Not Specified – No dosage adjustment required
Note: Renal impairment: No dosage adjustment required
Administration
  • Can be taken with food
  • Swallow tablets whole
Side Effect

Drug Interaction

Drug NameRisk Factors
Strong CYP2C8 inhibitors
May result in significant increase in exposure to selexipag and its active metabolite; avoid concomitant administration
Rifampin
Halved exposure to active metabolite; increase dose up to twice of the normal dose when co-administered

Disease Interaction

Disease NameRisk Factors
No specific contraindications listed
Monitor for general drug reactions

Pregnancy

Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage

Details coming soon

Data Sources

Clinical & regulatory information on this page is compiled from the following government sources:

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.